Atabak Mokari serves as the Chief Financial Officer and Treasurer at Corcept Therapeutics Inc., a position he has held since joining the company in 2019. With a robust background in finance and a keen strategic mindset, Mokari has been instrumental in steering the financial direction of Corcept Therapeutics, a biopharmaceutical company focused on the development and commercialization of medications for severe metabolic, oncologic, and psychiatric disorders. Prior to his role at Corcept, Mokari held various leadership positions that honed his expertise in financial management and corporate strategy. Before joining Corcept, Mokari served as the CFO at Anacor Pharmaceuticals, where he played a pivotal role in the company's growth and eventual acquisition by Pfizer for $5.2 billion in 2016. His tenure at Anacor was marked by successful financial planning and investor relations that significantly enhanced the company's market position. Mokari also spent over a decade at J.P. Morgan in various capacities, including as an Executive Director in the healthcare investment banking group, where he advised on numerous mergers, acquisitions, and financings. His extensive experience in the financial sector, particularly within the healthcare industry, has been a key asset to Corcept Therapeutics. In his current role at Corcept, Mokari is responsible for overseeing all financial aspects of the company, including financial planning and analysis, accounting, treasury, and investor relations. Under his leadership, Corcept has continued to expand its product offerings and strengthen its financial position, enabling the company to invest in research and development initiatives aimed at addressing unmet medical needs. Mokari's strategic vision and financial acumen have been crucial in driving Corcept's growth and ensuring its long-term success in the competitive biopharmaceutical market.